24/7 Market News Snapshot 23 July, 2025 – Anebulo Pharmaceuticals, Inc. Common Stock (NASDAQ:ANEB)

July 23, 2025

DENVER, Colo., 23 July, 2025 (www.247marketnews.com) – (NASDAQ:ANEB) are discussed in this article.
Anebulo Pharmaceuticals, Inc. is witnessing a significant surge in market activity, with shares currently trading at $3.103, a remarkable increase of 69.56% from the last closing price of $1.830. This bullish trend indicates heightened investor interest, bolstered by a trading volume of 4.47 million shares. The optimism surrounding Anebulo’s innovative focus on addressing acute cannabis-induced toxicity has attracted considerable market attention.

In a strategic move aimed at enhancing operational efficiency and shareholder value, Anebulo’s Board of Directors has approved a recommendation from a Special Committee of independent directors to implement a reverse stock split. This split will range from 1-for-2,500 to 1-for-7,500, enabling the company to significantly reduce its number of shareholders. It is anticipated that this action will allow Anebulo to terminate its registration as a reporting company with the Securities and Exchange Commission (SEC), thus reducing the financial burdens tied to public reporting and freeing resources for product development.

As part of the restructuring, shareholders who hold fewer shares than the specified minimum—based on the final split ratio—will receive cash compensation at $3.50 per pre-split share, representing a notable 91% premium over the current stock price. Those retaining more than the minimum will maintain ownership of their shares post-split.

Anebulo remains dedicated to advancing its lead candidate, selonabant, with a particular emphasis on developing a new intravenous formulation to treat acute cannabinoid intoxication in pediatric populations. The Board will maintain discretion over the reverse stock split process, ensuring it aligns with the best interests of the company and its shareholders. Further updates regarding these developments will be communicated to stakeholders as they are formalized.

Related news for (ANEB)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.